Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an AI-powered clinical assistant to aid ...

A new bone marrow test can help doctors predict risk of leukemia relapse. The test might double survival rates by predicting ...

RFK Jr. wants placebo trials for vaccines. A Northwestern researcher says that's unethical.

Last time there was no status LED included in the design, and the recessed reset switch and micro-USB power input were on ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

The U.S. Food and Drug Administration (FDA) approved Kamada's application to manufacture CYTOGAM in May 2023. During the year ...

Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball ...

Johnson & Johnson (NYSE: JNJ) today announced new data from the TREMFYA® (guselkumab) Phase 3 QUASAR long-term extension (LTE) study in adults with moderately-to-severely active ulcerative colitis (UC ...

Neurocrine Biosciences, Inc. today announced the release of findings from a new survey conducted by The Harris Poll highlighting the profound negative impact of tardive dyskinesia on patients and ...

ORLADEYO net revenue of $134.2 million (+51 percent y-o-y)- -Full year 2025 ORLADEYO revenue guidance increased to $580 million to $600 million- -Company now expects to be profitable for full ...

According to a couple of studies people with brown eyes have certain characteristics that make them special and uniqueThe studies found that browneyed people have a curious power of trust These indivi ...